Skip to main content
logo
MedinCell S.A. (EPA:MEDCL)
France flag France · Delayed Price · Currency is EUR
24.88
+0.76 (3.15%)
Aug 21, 2026, 5:35 PM CET

MedinCell Financials Overview

Millions EUR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
24.2824.2827.7311.9513.668.34
Revenue Growth
-25.16%-12.44%132.12%-12.52%63.77%1.86%
Gross Profit
24.2824.2827.7311.9513.668.34
Operating Income
-20.74-20.74-10.76-20.94-24.03-23.81
Net Income
-31.29-31.29-18.44-25.04-32.01-24.81
Earnings Per Share
-0.94-0.94-0.62-0.88-1.27-1.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
84.8284.8271.919.466.4726.59
Total Debt
71.9271.9267.3264.7157.7147.49
Net Cash (Debt)
12.9112.914.58-45.25-51.24-20.9
Net Cash Growth
-182.10%----
Net Cash Per Share
0.390.390.15-1.59-2.03-0.84

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-24.55-24.5519.47-11.92-21.01-21.36
Capital Expenditures
-0.82-0.82-0.75-0.32-0.58-1.62
Free Cash Flow
-25.37-25.3718.72-12.25-21.58-22.99
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-85.44%-85.44%-38.81%-175.30%-175.94%-285.58%
Pretax Margin
-129.16%-129.16%-65.92%-208.87%-234.42%-297.51%
Profit Margin
-128.88%-128.88%-66.50%-209.61%-234.42%-297.50%
FCF Margin
-104.50%-104.50%67.51%-102.52%-158.04%-275.67%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-93.6827.9668.0068.006.91
P/FCF Ratio
--25.44---
PS Ratio
36.8033.3417.1723.0818.0322.36